LEADER 03910nam  2201093z- 450 
001 9910566478403321
005 20240320172755.0
035   $a(CKB)5680000000037596
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81147
035   $a(EXLCZ)995680000000037596
100   $a20202205d2022      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAtherosclerosis$eTechnologies of Personalized Medicine
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (150 p.)
311   $a3-0365-3528-4 
311   $a3-0365-3527-6 
330   $aThe first national conference with international participation, ?Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine?, was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician?scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists.
517   $aAtherosclerosis
606   $aMedicine$2bicssc
606   $aCardiovascular medicine$2bicssc
610   $ametalloproteinases
610   $acalcification
610   $aatherosclerosis
610   $amultiplex assay
610   $acoronary heart disease
610   $aaspirin
610   $aresistance
610   $anon-sensitivity
610   $aantiplatelet
610   $alight transmission aggregometry
610   $aPlateletworks®
610   $afamilial hypercholesterolemia
610   $atargeted sequencing technologies
610   $amultiplex ligation-dependent probe amplification
610   $aLDLR
610   $aAPOB
610   $aABCG5
610   $aAPOC3
610   $aLPL
610   $aSREBF1
610   $arare variants
610   $acoronary atherosclerosis
610   $aischemic heart disease
610   $asaturated fatty acids
610   $amonounsaturated fatty acids
610   $apolyunsaturated fatty acids
610   $aoxidative stress
610   $asuperoxide dismutase
610   $acatalase
610   $aglutathione peroxidase
610   $acumulative LDL-C level
610   $aprognosis
610   $aDNA methylation
610   $aepigenetic age
610   $amyocardial infarction
610   $aacute coronary syndrome
610   $apopulation
610   $anested case-control
610   $aHAPIEE project
610   $aHAPIEE study
610   $aatrial fibrillation
610   $aarterial hypertension
610   $aobesity
610   $adiabetes mellitus
610   $aaging
610   $adeterminants
610   $aprevalence
610   $aRussian population cohort
610   $aCox regression analysis
610   $aadiponectin
610   $aleptin
610   $ainterleukin-6
610   $aepicardial adipose tissue
610   $aperivascular adipose tissue
610   $acirculating biochemical markers
610   $acoronary atherosclerosis presence and severity
610   $aintegrated biomarker (i-BIO)
610   $avalidation
610   $avisual markers
610   $alipoprotein(a)
610   $aimmune cells blood count
615  7$aMedicine
615  7$aCardiovascular medicine
700   $aRagino$b Yuliya I$4edt$01308060
702   $aRagino$b Yuliya I$4oth
906   $aBOOK
912   $a9910566478403321
996   $aAtherosclerosis$93029089
997   $aUNINA